Expression of cyclin D1 and retinoblastoma protein in colorectal cancer

European Journal of Cancer

Volumn 34, Issue 10, 1998, Pages 1575-1581

  Palmqvist, R ^a   Stenling, R ^a   Oberg A ^a   Landberg, G ^a  

^a UMEÅ UNIVERSITY   (Sweden)

Author keywords

Cell cycle control; Colorectal cancer; Cyclin D1; pRB

Indexed keywords

CYCLIN D1; KI 67 ANTIGEN; RETINOBLASTOMA PROTEIN;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CELL CYCLE; COLORECTAL CANCER; FEMALE; GENE FREQUENCY; HUMAN; IMMUNOHISTOCHEMISTRY; LABELING INDEX; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TUMOR GROWTH;

ADULT; AGED; AGED, 80 AND OVER; CELL DIVISION; COLORECTAL NEOPLASMS; CYCLIN D1; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MALE; MIDDLE AGED; NEOPLASM PROTEINS; NEOPLASM STAGING; PROGNOSIS; RETINOBLASTOMA PROTEIN; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 0032169107     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(98)00162-2     Document Type: Article

References (34)

1. 1. Riethmuller G, Schneider Gadicke E, Schlimok G, et al. Randomised trial of monoclonal antibody for adjuvant therapy of resected Dukes' C colorectal carcinoma. Lancet 1994, 343, 1177-1183.
2. 2. Bauer KD, Bagwell CB, Giaretti W, et al. Consensus review of the clinical utility of DNA flow cytometry in colorectal cancer. Cytometry 1993, 14, 486-491.
3. 3. Paradiso A, Rabinovich M, Vallejo C, et al. P53 and PCNA expression in advanced colorectal cancer - response to chemotherapy and long-term prognosis. Int J Cancer 1996, 69, 437-441.
4. 4. Rew DA. Cell proliferation, tumour growth and clinical outcome: gains and losses in intestinal cancer. Ann R Coll Surg Engl 1993, 75, 397-404.
5. 5. Sherr CJ. Cancer cell cycles. Science 1996, 274, 1672-1677.
6. 6. Hartwell LH, Kastan MB. Cell cycle control and cancer. Science 1994, 266, 1821-1828.
7. 7. Strauss M, Lukas J, Bartek J. Unrestricted cell cycling and cancer. Nat Med 1995, 1, 1245-1246.
8. 8. Landberg G, Nielsen NH, Nilsson P, Emdin SO, Cajander J, Roos G. Telomerase activity is associated with cell cycle deregulation in human breast cancer. Cancer Res 1997, 57, 549-554.
9. 9. Arber N, Hibshoosh H, Moss SF, et al. Increased expression of cyclin D1 is an early event in multistage colorectal carcinogenesis. Gastroenterology 1996, 110, 669-674.
10. 10. Bartkova J, Lukas J, Strauss M, Bartek J. The PRAD-1/cyclin D1 oncogene product accumulates aberrantly in a subset of colorectal carcinomas. Int J Cancer 1994, 58, 568-573.
11. 11. Maeda K, Chung YS, Kang SM, et al. Overexpression of cyclin Dl and p53 associated with disease recurrence in colorectal adenocarcinoma. Int J Cancer 1997, 74, 310-315.
12. 12. Gillett C, Smith P, Gregory W, et al. Cyclin D1 and prognosis in human breast cancer. Int J Cancer 1996, 69, 92-99.
13. 13. Wiman KG. The retinoblastoma gene: role in cell cycle control and cell differentiation. FASEB J 1993, 7, 841-845.
14. 14. Bookstein R, Shew JY, Chen PL, Scully P, Lee WH. Suppression of tumorigenicity of human prostate carcinoma cells by replacing a mutated RB gene. Science 1990, 247, 712-715.
15. 15. Lee EY, To H, Shew JY, Bookstein R, Scully P, Lee WH. Inactivation of the retinoblastoma susceptibility gene in human breast cancers. Science 1988, 241, 218-221.
16. 16. Venter DJ, Bevan KL, Ludwig RL, et al. Retinoblastoma gene deletions in human glioblastomas. Oncogene 1991, 6, 445-448.
17. 17. Ali AA, Marcus JN, Harvey JP, et al. RB1 protein in normal and malignant human colorectal tissue and colon cancer cell lines. FASEB J 1993, 7, 931-937.
18. 18. Gope R, Christensen MA, Thorson A, et al. Molecular analysis of retinoblastoma (Rb) gene in human colorectal carcinomas. In Utsunomiya J, Lynch HT, eds. Hereditary Colorectal Cancer Tokyo, Springer, 1990, 489-496.
19. 19. Chetty R, Subramoney T, Singh J, Harilal P. Retinoblastoma (pRb) protein immunoexpression in colorectal cancer. Anticancer Res 1997, 17, 2593-2597.
20. 20. Gope R, Christensen MA, Thorson A, et al. Increased expression of the retinoblastoma gene in human colorectal carcinomas relative to normal colonic mucosa. J Natl Cancer Inst 1990, 82, 310-314.
21. 21. Meling GI, Lothe RA, Borresen AL, et al. Genetic alterations within the retinoblastoma locus in colorectal carcinomas. Relation to DNA ploidy pattern studied by flow cytometric analysis. Br J Cancer 1991, 64, 475-480.
22. 22. Poller DN, Baxter KJ, Shepherd NA. p53 and Rb1 protein expression: are they prognostically useful in colorectal cancer? Br J Cancer 1997, 75, 87-93.
23. 23. Nielsen NH, Emdin SO, Cajander J, Landberg G. Deregulation of cyclin E and D1 in breast cancer is associated with inactivation of the retinoblastoma protein. Oncogene 1997, 14, 295-304.
24. 24. Xu HJ, Hu SX, Benedict WT. Lack of nuclear RB protein staining in G0/middle G1 cells: correlation to changes in total RB protein level. Oncogene 1991, 6, 1139-1146.
25. 25. Cordon-Cardo C, Zhang ZF, Dalbagni G, et al. Cooperative effects of p53 and pRb alterations in primary superficial bladder tumors. Cancer Res 1997, 57, 1217-1221.
26. 26. Gope R, Gope ML. Abundance and state of phosphorylation of the retinoblastoma susceptibility gene product in human colon cancer. Mol Cell Biochem 1992, 110, 123-133.
27. 27. Lukas J, Bartkova J, Rohde M, Strauss M, Bartek J. Cyclin D1 is dispensable for Gl control in retinoblastoma gene-deficient cells independently of cdk4 activity. Mol Cell Biol 1995, 15, 2600-2611.
28. 28. Betticher DC, Heighway J, Hasleton PS, et al. Prognostic significance of ccnd1 (cyclin D1) overexpression in primary resected non-small-cell lung cancer. Br J Cancer 1996, 73, 294-300.
29. 29. Lukas J, Bartkova J, Welcker M, et al. Cyclin D2 is a moderately oscillating nucleoprotein required for G1 phase progression in specific cell types. Oncogene 1995, 10, 2125-2134.
30. 30. Masuda M, Hirakawa N, Nakashima T, Kuratomi Y, Komiyama S. Cyclin D1 overexpression in primary hypopharyngeal carcinomas. Cancer 1996, 78, 390-395.
31. 31. Lindmark G, Glimelius B, Pahlman L, Enblad P. Heterogeneity in ploidy and S-phase fraction in colorectal adenocarcinomas. Int J Colorectal Dis 1991, 6, 115-120.
32. 32. Velders GA, Kluin Nelemans JC, De Boer CJ, et al. Mantle-cell lymphoma: a population-based clinical study. J Clin Oncol 1996, 14, 1269-1274.
33. 33. Michalides R, van Veelen N, Hart A, Loftus B, Wientjens E, Balm A. Overexpression of cyclin D1 correlates with recurrence in a group of forty-seven operable squamous cell carcinomas of the head and neck. Cancer Res 1995, 55, 975-978.
34. 34. Naitoh H, Shibata J, Kawaguchi A, Kodama M, Hattori T. Overexpression and localization of cyclin D1 mRNA and antigen in esophageal cancer. Am J Pathol 1995, 146, 1161-1169.